<DOC>
	<DOC>NCT01030224</DOC>
	<brief_summary>The main purpose of this study is to assess the safety, tolerability and PK of AZD9742 after single IV doses.</brief_summary>
	<brief_title>This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Provision of signed and dated, written informed consent prior to any study specific procedures. Clinically normal physical findings and laboratory values as judged by the investigator with normal ECG. Healthy male and female volunteers. Females must be of non childbearing potential. Clinically significant illness or clinically relevant trauma, as judged by the investigator, within 4 weeks of the first administration of the Investigational Product History of any disease or condition known to interfere with the absorption, distribution, metabolism or excretion of drugs</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>First time in human</keyword>
</DOC>